Organon & Co. (OGN)
8.13
-0.06
(-0.73%)
USD |
NYSE |
Jan 08, 16:00
8.20
+0.07
(+0.86%)
Pre-Market: 20:00
Organon Market Cap: 2.114B for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 275.48B |
| Amgen, Inc. | 177.76B |
| Regeneron Pharmaceuticals, Inc. | 84.19B |
| Rockwell Medical, Inc. | 38.53M |
| United Therapeutics Corp. | 21.13B |
Market Cap Related Metrics
| PE Ratio | 4.226 |
| PS Ratio | 0.336 |
| Price to Book Value | 2.333 |
| Price to Free Cash Flow | 3.540 |
| Price | 8.13 |
| Earnings Yield | 23.66% |
| Operating PE Ratio | 1.612 |
| Normalized PE Ratio | 3.792 |